Results 131 to 140 of about 1,619 (168)
Some of the next articles are maybe not open access.
British Journal of Dermatology, 2007
Indeterminate cell histiocytosis (ICH) is a proliferation of indeterminate CD1a+, CD68+, S100+ and CD207- dermal dendritic cells. We describe a 39-year-old man who developed diffuse ICH and, 6 years later, acute myeloblastic leukaemia (AML). He was treated with cyclophosphamide, etoposide and vinblastine until 2003.
C. Vener +8 more
openaire +2 more sources
Indeterminate cell histiocytosis (ICH) is a proliferation of indeterminate CD1a+, CD68+, S100+ and CD207- dermal dendritic cells. We describe a 39-year-old man who developed diffuse ICH and, 6 years later, acute myeloblastic leukaemia (AML). He was treated with cyclophosphamide, etoposide and vinblastine until 2003.
C. Vener +8 more
openaire +2 more sources
Indeterminate cell histiocytosis treated successfully with 2-chlorodeoxyadenosine.
Cutis, 1997We report the case of a 54-year-old man with a ten-year history of a generalized papular eruption consistent with the diagnosis of indeterminate cell histiocytosis. The patient responded favorably to a course of treatment with 2-chlorodeoxyadenosine.
M S, Daoud +3 more
openaire +1 more source
A Case of Indeterminate Cell Histiocytosis
Nishi Nihon Hifuka, 2020Seisho SATO +9 more
openaire +1 more source
A Case of Solitary Indeterminate Cell Histiocytosis
The Journal of Dermatology, 2003Yasuyuki, Amo +3 more
openaire +2 more sources
Case 51. Indeterminate dendritic cell histiocytosis
2021E. Akufo-Tetteh +2 more
openaire +1 more source
Chemotherapeutic experience in indeterminate cell histiocytosis
British Journal of Dermatology, 2005R. Caputo +3 more
openaire +2 more sources
Nonoperative Management of Childhood Calvarial Langerhans-Cell Histiocytosis
New England Journal of Medicine, 2022David D Limbrick +2 more
exaly
Treatment of indeterminate cell histiocytosis with pravastatin
Journal of the American Academy of Dermatology, 2011Molly V. Burns +4 more
openaire +1 more source

